Rieg, Timo http://orcid.org/0000-0001-6082-662X
Vallon, Volker
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK112042)
Article History
Received: 15 March 2018
Accepted: 23 March 2018
First Online: 22 August 2018
Duality of interest
: Over the past 36 months, VV has served as a consultant and received honoraria from Bayer, Boehringer Ingelheim, Intarcia Therapeutics, Astra-Zeneca, Janssen Pharmaceutical, Eli Lilly and Merck, and received grant support for investigator-initiated research from Astra-Zeneca, Bayer, Boehringer Ingelheim, Fresenius and Janssen.
Free to read: This content has been made available to all.